Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma

Por Lode, Holger N., Dreier, Torsten, Xiang, Rong, Varki, Nissi M., Kang, Angray S., Reisfeld, Ralph A.
Publicado em 1998

Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions

Por Beirnaert, Els, Desmyter, Aline, Spinelli, Silvia, Lauwereys, Marc, Aarden, Lucien, Dreier, Torsten, Loris, Remy, Silence, Karen, Pollet, Caroline, Cambillau, Christian, de Haard, Hans
Publicado no Front Immunol (2017)

ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade

Por Silence, Karen, Dreier, Torsten, Moshir, Mahan, Ulrichts, Peter, Gabriels, Sofie ME, Saunders, Michael, Wajant, Harald, Brouckaert, Peter, Huyghe, Leander, Van Hauwermeiren, Tim, Thibault, Alain, De Haard, Hans J
Publicado em 2014

Four individually druggable MET hotspots mediate HGF-driven tumor progression

Por Basilico, Cristina, Hultberg, Anna, Blanchetot, Christophe, de Jonge, Natalie, Festjens, Els, Hanssens, Valérie, Osepa, Sjudry-Ilona, De Boeck, Gitte, Mira, Alessia, Cazzanti, Manuela, Morello, Virginia, Dreier, Torsten, Saunders, Michael, de Haard, Hans, Michieli, Paolo
Publicado em 2014

Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans

Por Ulrichts, Peter, Guglietta, Antonio, Dreier, Torsten, van Bragt, Tonke, Hanssens, Valérie, Hofman, Erik, Vankerckhoven, Bernhardt, Verheesen, Peter, Ongenae, Nicolas, Lykhopiy, Valentina, Enriquez, F. Javier, Cho, JunHaeng, Ober, Raimund J., Ward, E. Sally, de Haard, Hans, Leupin, Nicolas
Publicado no J Clin Invest (2018)

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

Por Newland, Adrian C., Sánchez‐González, Blanca, Rejtő, László, Egyed, Miklos, Romanyuk, Nataliya, Godar, Marie, Verschueren, Katrien, Gandini, Domenica, Ulrichts, Peter, Beauchamp, Jon, Dreier, Torsten, Ward, E. Sally, Michel, Marc, Liebman, Howard A., de Haard, Hans, Leupin, Nicolas, Kuter, David J.
Publicado no Am J Hematol (2019)

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

Por Howard, James F., Bril, Vera, Burns, Ted M., Mantegazza, Renato, Bilinska, Malgorzata, Szczudlik, Andrzej, Beydoun, Said, Garrido, Francisco Javier Rodriguez De Rivera, Piehl, Fredrik, Rottoli, Mariarosa, Van Damme, Philip, Vu, Tuan, Evoli, Amelia, Freimer, Miriam, Mozaffar, Tahseen, Ward, E. Sally, Dreier, Torsten, Ulrichts, Peter, Verschueren, Katrien, Guglietta, Antonio, de Haard, Hans, Leupin, Nicolas, Verschuuren, Jan J.G.M.
Publicado no Neurology (2019)